The combination of STING activation, ICD, andimmunomodulation effectively reprograms the TME, enhances DC and CD8+ T cell activation, and suppresses tumor progression and metastasisin multiple tumor models, including immunologically cold tumors likeglioblastoma and PDAC. Here, STING1 is linked to neoplasm.